Statement of Clinical Relevance
We found that oral verrucous carcinomas and hyperplasias are rarely associated with human papillomavirus infection. Our next-generation sequencing methodology allowed us to test for all human viruses. We conclude that papillomavirus infections are not involved in the development of these tumors. Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer in the world, with an incidence of about 600 000 cases each year and a 5-year survival rate of only about 50%. 1 Around half of these cases occur in the oral cavity. 2 Most cases represent oral squamous cell carcinoma (OSCC), which is found mainly in older men exposed to tobacco and alcohol. 3 Verrucous carcinoma (VC) is a low-grade variant of squamous cell carcinoma (SCC) that rarely presents with distant metastasis. 4 The association between human papillomavirus (HPV) and HNSCC is strongest among oropharyngeal squamous cell carcinomas (OPSCC), especially for cancers of the lingual and palatine tonsils. 5, 6, 7, 8 and 9 Furthermore, the risk of developing oropharyngeal cancer when adjusted for tobacco and alcohol use is substantially increased with highrisk HPV oral infections. 9 HPV has been identified in 45% to 95% of OPSCC 10, 11 and 12 and is believed to be an etiologic agent. 13 In 2012, Kansy et al. 14 conducted a systematic review encompassing 5338 patients to assess the role of high-risk HPV types in OSCC, and 30.1% revealed HPV-positive OSCC samples. Within this review, HPV type 16 was identified in 25.4% and type 18 in 18.1%. However, the role of HPV as a causative factor was not well defined. In general, HPV-positive carcinomas have better prognosis and treatment response than HPV-negatives. 13, 15 and 16 Studies find a 2-to 3-year overall survival rate of about 60% for HPV-negative HNSCC, compared with about 85% for HPV-positives, 15 and 16 indicating the importance of accurate HPV detection and subtyping.
Oral verrucous carcinoma (OVC) accounts for 2% to 10% of all OSCC cases. 17 'Verrucous' terminology is applied to lesions that show exophytic, keratotic surfaces made of blunt or sharp epithelial projections, filled with keratin invaginations, but without clear fibrovascular cores. 18 Histologically, OVC consists of thickened, club-shaped papillae and blunt stromal invaginations of well-differentiated squamous epithelium with marked keratinization (Figure 1, A, B) , with the squamous epithelium lacking cytologic criteria of malignancy. OVC invades underlying stroma with a pushing, rather than infiltrating, front. 19 Oral verrucous hyperplasia (OVH) ( Figure 2 ) and proliferative verrucous leukoplakia are both poorly defined but are believed to be histologic precursors of OVC and possibly OSCC. 20 and 21 Because a verrucous appearance suggests a viral etiology, this has prompted a number of investigations for HPV. 22 and 23 Patel et al. 24 recently concluded that verrucous carcinomas of the head and neck lacked transcriptionally active high-risk human papillomavirus, but they concluded with "our study numbers, although relatively generous for a tumor as rare as verrucous carcinoma, are still relatively small and may not reflect results on larger cohorts of these tumors."
Fig. 1
A, Photomicrograph of oral verrucous carcinoma showing 'extension' into underlying mucous salivary glands. It 'retains' the bulbous rete seen in verrucous hyperplasia, but clearly has a 'pushing' advancing front that now extends considerably deeper than adjacent normal epithelium (hematoxylin-eosin, original magnification approximately × 100). 
B,

Fig. 2.
A, B, Photomicrograph of oral verrucous hyperplasia showing markedly acanthotic epithelium, with bulbous, clubshaped papillae lacking significant cellular atypia (A), adjacent to more normal epithelium (B) (A, B, hematoxylin-eosin, original magnification approximately ×250). In comparison with Figure 1 , the affected epithelium does not show any significant 'deep extension. ' Most studies (TableI) 23, 25, 26, 27, 28, 29, 30 and 31 relied on polymerase chain reaction (PCR) or in situ hybridization for detection and did not identify HPV transcriptional activity markers, did not quantitate HPV viral load, or relied on a low sample number. Koskinen et al. 32 reported that 37 of 61 (61%) head and neck cancer samples were positive for HPV and that HPV-16 was the most frequently detected type (31 of 37, 84%). The aim of this study was to analyze a large cohort of oral verrucous lesions for the presence of HPV subtypes, as well as any other viral genomes, using next-generation sequencing (NGS). The cohort included VC and VH but excluded so-called hybrid lesions where VC and infiltrative SCC exist, 19 as well as lesions with distant metastases, as these lesions are not representative of 'classical' VC.
Materials and Methods
Sample selection
Of the samples included, 28 
DNA extraction
Seven 10-μm sections were cut from each block onto plain glass slides. Premalignant or malignant areas were microscopically identified and marked on a corresponding hematoxylin-eosin-stained slide. Sections were dewaxed and macrodissected with a sterile scalpel blade to obtain >70% tumor cell content for DNA isolation, performed using Qiagen DNA extraction kits (Qiagen, Sussex, United Kingdom), according to the manufacturer's instructions. DNA extraction was successful in 78 cases.
Determining DNA concentration and purity
Nucleic acid concentration and purity were measured using the NanoDrop UV spectrophotometer NanoDrop-8000 (Thermo Scientific, Wilmington, DE, USA). Besides the concentration, A260:230 and A260:280 ratios were obtained, which are used as indicators of the purity of the samples. Double-stranded DNA concentration was specifically quantified using the Quant-iT PicoGreen dsDNA BR assay (Invitrogen, Paisley, United Kingdom). Of 94 cases, 78 yielded sufficient DNA for library preparation and NGS analysis.
Library preparation and sequencing
Library preparation for Illumina Genome analyser GAIIx sequencing
Briefly, between 5 ng and 1 μg of DNA was sheared on a Covaris S2 Sample Preparation System (Covaris Inc, Woburn, MA, USA). Sheared DNA samples were checked for appropriate size distribution according to the manufacturer's instructions on an Agilent Bioanalyser DNA 1000 LabChip (Agilent Technologies Inc, Santa Clara, CA, USA). The End-It DNA End-Repair Kit (Epicentre Biotechnologies, Madison, WI, USA) was used to convert DNA with damaged ends to blunt-ended, 5′-phosphorylated DNA.
Klenow DNA polymerase was used to add an A base to each blunt-ended DNA fragment so that adapters could be ligated. Six base pairs (bp) of unique oligonucleotide tag sequence (adapter) were ligated to the ends of the DNA fragments using methods previously published. 33 
Human genomic copy number analysis
Human DNA copy number analysis was calculated and analyzed as recently described. 34 Sample reads were arranged and organized by chromosome and position. The ratio of test to control reads was calculated across the genome in equally sized windows, averaging 200 tumor reads. A control sample was pooled from a group of 20 data sets for normal individuals downloaded from the 1000 Genomes Project 35 (ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp).
Viral genomes, HPV subtype detection, and load measurements by sequencing
Viral load was measured as previously described by Conway et al. 36 This technique has been found to have good sensitivity and specificity, with the additional benefits of providing information on viral subtype and load but also informing genomic copy number. The number of reads aligning to the human genome was used to calculate read depth, in terms of reads per Kb. (For example, 1 million human reads in a 6-Gb diploid human genome equates to 1 read for every 6 Kb of human DNA.) Next, the number of reads uniquely aligning to viral genomes was counted. This was equated to a certain number of Kb viral sequence per human genome and hence the number of viral genomes per human genome. (For example, if 5 HPV reads are detected, and we have previously calculated that there is 1 read every 6 Kb, then there is likely to be around 30 Kb of viral DNA per cell. This is equivalent to 30/7.9 = 3.8 viral genomes per cell.) We can also calculate the probability of detecting 1 copy of the HPV genome per cell, as follows:
p=1-e (0-(7900-bp viral genomex number of human reads)/6 billion-bp diploid human genome)
So a sample with 1 million human reads has a 73% chance of detecting a single copy of the HPV genome per cell, whereas a sample with 3 million reads has a 98% chance. Higher viral loads will be easier to detect. Given a certain number of human reads, the possible viral load that could be detected with 95% confidence is as follows:
(0-log(1-0,95)x6-Mb diploid human genome)/(7.9-Kb viral genomexnumber of human reads) So, for example, only 456 000 reads are needed to detect a load of 5 viral copies per cell with 95% confidence.
We used HPV sequencing data from a previous study (from our group) that included positive and negative controls.36 NGS in HPV-positive cases was compared with the gold standard of p16 immunohistochemistry (antibody F-12: Sc-1661; Santa Cruz Biotechnology Inc) using high-pH range settings on Dako Autostainer Link 48 (Ely, United Kingdom) and found to be comparable in sensitivity and specificity.
Results
A total of 78 patients, including 41 women and 37 men (mean age, 67 years; range, 38-96) were included (Table II) . Full data are given in Supplemental Table S1 , available at www.oooojournal.net. Tumor DNA was extracted from a total of 94 samples, and 78 (83%) of these yielded sufficient DNA for library preparations and NGS. Neither the age of the formalin-fixed, paraffin-embedded block nor the amount of tissue sampled correlated with low yields. 
Human herpesvirus
Human herpesvirus (HHV) sequences were detected in 22 of 78 samples (6 OVHs and 16 OVCs) with viral loads ranging from 0.01 to 0.58 viral genomes per cell (see Table III ) and with 0.19 viral loads SD. There were 12 samples positive for HHV-1, 1 for HHV-4, 4 for HHV-5, 5 for HHV-6B, 3 for HHV-6A, and 1 for HHV-7. Four cases had double HHV infections (HHV-1 and -5, HHV-1 and -6A, HHV-1 and -6B, and HHV-6A and -6B).
Discussion
We have described the use of NGS as a validated, powerful, high-throughput method to investigate the presence of all characterized human viral genome loads and subtypes, in the largest, specifically oral, verrucous sample cohort described to date. Using NGS, testing for all HPV subtypes found HPV-16 positivity in only 1 OVH and 1 OVC sample and HPV-2 positivity in 1 OVC sample out of 78 oral verrucous lesions with 2.2, 8.1, and 0.3 viral genomes per cell, respectively. Although it is difficult to accurately predict the exact viral load with only a very small number of aligning viral reads, loads in this study were much lower than loads in our previous study of HNSCC. 36 There the standard deviation of the viral loads was 37.7, suggesting that the virus was not contributing to disease etiology. We have calculated the probability of detecting a viral load of 1 HPV genome per cell, given our read numbers. Of our 78 samples, 60 have sufficient depth to detect 1 HPV genome per cell. All but 4 samples have sufficient depth to be able to detect 4 copies per cell with 95% confidence.
HPV DNA may degrade in paraffin-embedded tissues. Sequencing may be less affected by this than PCR. The standard PCR test for HPV requires a 120-bp fragment to be amplified. We size select our libraries to be around 200 bp to ensure that enough fragments of <100 bp are sequenced. If an HPV sequence is in one of these, it would be picked up by sequencing but not by PCR.
The recent article by Patel et al. 24 used HPV reverse transcription PCR (RT-PCR) testing, but they had a significant subset of cases in which insufficient RNA from the formalin-fixed, paraffin-embedded tumor sections precluded HPV RT-PCR testing. Nevertheless, they concluded that "active HPV in (head and neck) verrucous carcinomas is rare enough to likely be clinically inconsequential."
In 2012, del Pino et al. 23 investigated the prevalence of HPV in 18 verrucous lesions.
Using PCR, and finding that only 1 head and neck VC was positive for HPV infection, the authors concluded that VC is "unlikely to be related to HPV infection." In addition, Stokes et al. 25 studied the role of HPV in malignant and dysplastic oral verrucous lesions and suggested that although high-risk HPV DNA was identified in 1 of 7 carcinomas and 5 of 13 dysplasias, the oncogenic process is not enhanced by HPV oncoproteins, as p16 overexpression was lacking; they concluded that further work is needed on a larger cohort to determine HPV's biologic significance in VC development.
We have used NGS for the detection of HPV in verrucous samples on the largest cohort of oral verrucous carcinomas to date. In addition, we used histologic diagnostic criteria defined by the World Health Organization, 19 suggesting (unlike Patel et al. 24 ) that oral verrucous lesions with frank stromal invasion in the bulk of the tumor should be classified as SCCs with verrucous architecture and therefore should be excluded from study.
Our method using NGS was validated previously (on our control sample set) by detecting HPV sequences using PCR and by evaluating p16 expression as a marker for HPV infection. 36 We found in our previous study that NGS has a high specificity and sensitivity for HPV detection when compared with PCR and p16. It has been previously suggested that PCR methods can be oversensitive, 37 whereas our method can provide better specificity, as demonstrated by our observation that all p16-positive samples were also positive for HPV-16 by sequencing. 36 NGS has also been validated for detecting papilloma subtypes and loads not identified by other means in cervical samples. 38 In this study, we searched for all human viruses with sequenced genomes. HHV types were detected in one-third of lesions, although they were unconfirmed using any other diagnostic test. NGS tells us nothing about transcriptional activity, so it is not possible to speculate further on the clinical significance of this finding. In addition, we scanned the control samples used in our previous study 36 for all human virus sequences and identified 8 positive cases (34.78%). In general, herpes simplex virus-related infections are common, affecting approximately two-thirds of adults. Two HHV types known to be associated with cancer, Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus, 39 were not detected. Herpes infection may not be the cause of the disease in our patients, but future studies of a similar nature may reveal previously unsuspected oncoviruses to be common in a different tumor type. The fact that our read depth is enough to detect 1 HPV copy per cell with 95% confidence in most of our samples and a modest infection of 5 copies per cell in all but 5, combined with our previous ease of detecting HPV in oropharyngeal cancer, confirms that the absence of detection of HPV in this large sample is not a technical error but a real biologic finding.
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